Cas:36311-34-9 14-Methyl-1-pentadecanol manufacturer & supplier

We serve Chemical Name:14-Methyl-1-pentadecanol CAS:36311-34-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

14-Methyl-1-pentadecanol

Chemical Name:14-Methyl-1-pentadecanol
CAS.NO:36311-34-9
Synonyms:14-methyl-pentadecan-1-ol;14-Methyl-1-pentadecanol;MFCD00044080;1-Pentadecanol, 14-methyl-
Molecular Formula:C16H34O
Molecular Weight:242.441
HS Code:

Physical and Chemical Properties:
Melting point:49.3ºC
Boiling point:304.4±10.0 °C at 760 mmHg
Density:0.8±0.1 g/cm3
Index of Refraction:1.447
PSA:20.23000
Exact Mass:242.260971
LogP:7.07

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 14-methyl-pentadecan-1-ol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-Pentadecanol, 14-methyl- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,14-Methyl-1-pentadecanol Use and application,1-Pentadecanol, 14-methyl- technical grade,usp/ep/jp grade.


Related News: That’s four days earlier than it had initially planned. Delta’s last China-bound flight left on Saturday, February 1, and its final returning flight from China to the United States leaves on Sunday. 14-Methyl-1-pentadecanol manufacturer That’s four days earlier than it had initially planned. Delta’s last China-bound flight left on Saturday, February 1, and its final returning flight from China to the United States leaves on Sunday. 14-Methyl-1-pentadecanol supplier That’s four days earlier than it had initially planned. Delta’s last China-bound flight left on Saturday, February 1, and its final returning flight from China to the United States leaves on Sunday. 14-Methyl-1-pentadecanol vendor Today, Novavax is one step closer to addressing the critical and persistent global public health need for additional COVID-19 vaccines,” Novavax president and CEO Stanley Erck said in a statement. “These clinical results reinforce that [the vaccine] is extremely effective and offers complete protection against both moderate and severe COVID-19 infection. 14-Methyl-1-pentadecanol factory Novavax, a Maryland biotechnology company that has struggled mightily with delays in developing its coronavirus vaccine, announced Monday that its two-shot regimen was over 90% effective overall in a trial that unfolded even as more contagious variants emerged.